• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study Evaluates Factors Linked to Chronic Subdural Hematoma Recurrence After Surgery

by
November 6, 2026
in Health
Reading Time: 6 mins read
0
Study Evaluates Factors Linked to Chronic Subdural Hematoma Recurrence After Surgery

Study Evaluates Factors Linked to Chronic Subdural Hematoma Recurrence After Surgery

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a retrospective cohort study investigating chronic subdural hematoma recurrence following surgical evacuation, researchers found that approximately one in five patients experienced a recurrent hematoma during postoperative follow-up. Conducted at the Department of Neurosurgery within Hassani Abdelkader Hospital in Sidi Bel Abbès, Algeria, the investigation evaluated fifty-seven consecutively treated patients who underwent surgical procedures to evacuate these intracranial collections. Postoperative recurrence was documented in thirteen patients, representing an overall recurrence rate of 22.8 percent across the cohort. Every recurrent case was confirmed using computed tomography imaging, with seven patients exhibiting clinical symptoms while six were detected through radiological surveillance without new neurological complaints. The median interval from surgical evacuation to recurrence was thirty-nine days, with an interquartile range of twenty-two to fifty-five days and a range from eight to eighty-nine days. Among the evaluated clinical, radiological, hematological, and surgical characteristics, preoperative direct oral anticoagulant use was the sole factor significantly associated with recurrence.

Chronic subdural hematoma is among the most common neurosurgical conditions, particularly in older adults, and its incidence is expected to rise as populations age and antithrombotic therapy expands. The condition involves an encapsulated accumulation of old blood and fluid degradation products in the subdural space, driven by complex physiological mechanisms beyond simple mechanical rupture of bridging veins. Pathophysiological processes include chronic inflammation and angiogenesis within the outer hematoma membrane, fragile neomembrane capillaries, local fibrinolysis, and recurrent microhemorrhages promoting fluid persistence and hematoma expansion. Although surgical evacuation remains standard therapy—principally performed via burr-hole craniostomy, twist-drill craniostomy, or craniotomy—postoperative recurrence requiring secondary intervention remains a well-recognized challenge. Published literature reports recurrence rates ranging from 5 to 30 percent, with randomized trial evidence confirming that closed subdural drainage reduces recurrence from 24 percent to 9.3 percent.

The demographic and clinical presentation of the Algerian cohort reflected established epidemiological patterns of chronic subdural hematoma, showing advanced age and male predominance. Across the fifty-seven patients identified from single-batch institutional records, the median age was 78 years, with an interquartile range of 68 to 83 years, a mean of 75.9 years, and an overall range from 53 to 96 years. Male patients accounted for 73.7 percent of the cohort, while female patients represented 26.3 percent. At hospital admission, patients exhibited a median Glasgow Coma Scale score of 14, with an interquartile range of 13 to 15 and a mean score of 13.8. Headache was the most prevalent presenting symptom, occurring in 68.4 percent of patients, followed by focal neurological deficits in 50.9 percent, cognitive decline in 35.7 percent, and altered mental status in 33.3 percent. Prior falls or trauma were noted in 57.9 percent, while hypertension affected 59.6 percent, diabetes mellitus 31.6 percent, and previous chronic subdural hematoma 8.8 percent.

Preoperative medical assessments also documented antithrombotic medication use alongside routine hematological and biochemical laboratory parameters. Antiplatelet medications were taken by fourteen patients, representing 24.6 percent of the cohort, including aspirin in eleven patients and clopidogrel in five patients. Anticoagulant regimens were recorded in nine patients, or 15.8 percent, comprising warfarin in five patients, direct oral anticoagulants in four patients, and heparin or low-molecular-weight heparin in one patient. Laboratory testing established a median preoperative hemoglobin concentration of 12.8 grams per deciliter, with an interquartile range of 11.3 to 14.0 grams per deciliter and a mean of 12.6 grams per deciliter. The median platelet count was 214.0 times ten to the ninth per liter, with an interquartile range of 168.0 to 267.0 times ten to the ninth per liter. Baseline international normalized ratio measurements exhibited a median of 1.14 and an interquartile range of 1.02 to 1.22, demonstrating that gross systemic coagulation values remained predominantly non-pathological prior to surgical treatment.

Preoperative neuroimaging through computed tomography provided comprehensive characterization of hematoma anatomical distribution, volume, and internal architecture. Laterality assessments showed left-sided lesions in 49.1 percent of patients, right-sided hematomas in 38.6 percent, and bilateral collections in 12.3 percent. Quantitative measurements revealed a median maximum hematoma thickness of 18.1 millimeters, with an interquartile range of 14.6 to 23.1 millimeters and a mean of 18.6 millimeters, alongside a median midline shift of 2.6 millimeters with an interquartile range of 1.0 to 4.4 millimeters. Estimated hematoma volume showed a median of 140.7 milliliters and an interquartile range of 111.7 to 166.2 milliliters. Radiological density classifications demonstrated hypodense hematomas in 29.8 percent of patients, mixed density in 28.1 percent, isodense in 24.6 percent, and hyperdense in 17.5 percent. Internal structural septations were identified in 26.3 percent of cases and membranes in 35.1 percent. Brain atrophy was graded as absent in 24.1 percent, mild in 27.8 percent, moderate in 31.5 percent, and severe in 16.7 percent of the fifty-four evaluated cases.

Surgical evacuation procedures followed established neurosurgical techniques, with postoperative drainage systems deployed in most patients. Burr-hole craniostomy was performed in forty-two patients, representing 73.7 percent of the cohort, while twist-drill craniostomy was conducted in nine patients, or 15.8 percent, and open craniotomy in six patients, or 10.5 percent. Intraoperative irrigation was carried out in forty patients, accounting for 70.2 percent of operations. Postoperative closed drains were utilized in fifty-one patients, or 89.5 percent of the cohort, with subdural placement used in thirty-six patients and subperiosteal placement in fifteen patients. Drains remained in place for a median duration of 49.0 hours, with an interquartile range of 34.0 to 57.5 hours and a mean of 48.9 hours. Postoperative computed tomography imaging was completed in fifty-three patients at a median of four days post-surgery, demonstrating residual hematoma in twenty-five of those fifty-three evaluated cases, or 47.2 percent, while one in-hospital death occurred in a patient without recurrence.

Following surgical treatment, thirteen patients developed confirmed recurrence, presenting distinct clinical trajectories and secondary management approaches. All thirteen recurrent cases were verified radiologically on computed tomography imaging. Among these recurrences, seven patients experienced new or worsening clinical symptoms, while six patients presented as asymptomatic radiological recurrences identified during routine follow-up examinations. Reoperation was performed in six of the recurrent patients, representing 46.2 percent of recurrences, consisting of repeat burr-hole drainage in three patients and open craniotomy in three patients. The remaining seven recurrent patients, comprising 53.8 percent, did not undergo repeat surgery, though specific conservative measures were not detailed in the supplied records. Across the entire fifty-seven-patient cohort, clinical follow-up extended for a median duration of 116 days, with an interquartile range of 75 to 144 days and a range from 34 to 246 days, providing sufficient observation time to monitor postoperative recovery and recurrence events.

Statistical comparisons between patients with recurrence and those without revealed no statistically significant differences among all continuous variables evaluated. Utilizing the non-parametric Mann-Whitney U test, patient age did not differ significantly, showing a median of 72 years in recurrent cases compared to 78 years in non-recurrent cases, producing a p-value of 0.66. Admission Glasgow Coma Scale scores showed no significant variation between groups with a p-value of 0.10. Quantitative radiological measurements exhibited median hematoma thickness of 20.4 millimeters in recurrent cases versus 17.55 millimeters in non-recurrent cases, yielding a p-value of 0.20, while midline shift produced a p-value of 0.27 and preoperative hematoma volume showed a p-value of 0.55. Laboratory measures showed no significant differences, with hemoglobin producing a p-value of 0.77, platelet count 0.59, and international normalized ratio 0.83. Postoperative drain duration yielded a p-value of 0.26, while the number of burr holes showed a non-significant trend toward higher counts in recurrent cases, with a Mann-Whitney p-value of 0.087.

Among categorical variables evaluated using Fisher’s exact test, direct oral anticoagulant therapy emerged as the only characteristic significantly associated with recurrence. Recurrence occurred in three of four patients taking direct oral anticoagulants, representing 75.0 percent, compared with ten recurrences among fifty-three non-users, or 18.9 percent, yielding a significant p-value of 0.034. Other dichotomous variables showed no statistically significant relationship with recurrence. Patient sex exhibited recurrence in 28.6 percent of males compared to 6.7 percent of females, with a p-value of 0.15. Antiplatelet medication use showed recurrence in 14.3 percent of exposed patients versus 25.6 percent of unexposed individuals, with a p-value of 0.48. Antecedent trauma history, mixed radiological density, septations, membranes, and drain placement also showed no statistically significant associations with recurrence.

Multi-category variables were analyzed descriptively, with recurrence noted in 28.6 percent of bilateral hematomas, 32.1 percent of left-sided lesions, and 50.0 percent of hyperdense collections. All thirteen recurrences occurred following burr-hole craniostomy, while twist-drill and craniotomy subgroups experienced zero recurrences. The authors emphasized that the cohort of fifty-seven patients and thirteen recurrence events provided limited statistical power, precluding multivariable modeling and increasing the risk of false-negative findings. Furthermore, because no multiple testing correction was applied, the observed direct oral anticoagulant association rests on only four exposed individuals. Consequently, these findings represent hypothesis-generating associations that require validation in larger, prospective multicenter studies before guiding perioperative management.

Subject of Research: Recurrence factors after surgical evacuation of chronic subdural hematoma

Article Title: Clinical, radiological, and hematological correlates of recurrence after surgical evacuation of chronic subdural hematoma: a retrospective cohort study

Article References: Omar, Y. A., & Omar, I. A. (2026). Clinical, radiological, and hematological correlates of recurrence after surgical evacuation of chronic subdural hematoma: a retrospective cohort study. Egyptian Journal of Neurosurgery, 41(1), Article 185. https://doi.org/10.1186/s41984-026-00696-7

Image Credits: AI Generated

DOI: 10.1186/s41984-026-00696-7

Keywords: chronic subdural hematoma, neurosurgery, hematoma recurrence, burr-hole craniostomy, direct oral anticoagulants, computed tomography, surgical evacuation, postoperative drainage, Clinical, radiological, hematological, correlates

News Source: Ophelia Keating. (November 6, 2026). Study Evaluates Factors Linked to Chronic Subdural Hematoma Recurrence After Surgery. Scienmag.

Tags: burr-hole craniostomychronic subdural hematomaClinicalcomputed tomographycorrelatesdirect oral anticoagulantshematologicalhematoma recurrenceneurosurgerypostoperative drainageradiologicalsurgical evacuation
Share12Tweet7Share2ShareShareShare1

Related Posts

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

November 17, 2026
Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

November 17, 2026

Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

November 17, 2026

Empagliflozin Reduces Functional Tricuspid Regurgitation Without Inducing Ventricular Remodeling

November 17, 2026

POPULAR NEWS

  • Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

    Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

    29 shares
    Share 12 Tweet 7
  • Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

    29 shares
    Share 12 Tweet 7
  • Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

    29 shares
    Share 12 Tweet 7
  • Bacteriophages Suppress Resistant Pseudomonas aeruginosa Isolates in Laboratory Assessment

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.